ArticleAdvanced biotechnology2026
Phagocytotic impairment of tissue-resident alveolar macrophages by diesel particulates drives pulmonary surfactant accumulation.
Article in Advanced biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Airborne particulate matter, particularly diesel particulate matter (DPM), is a major component of air pollution and poses significant risks to lung health. Tissue-resident alveolar macrophages (TR-AMs), which dominate the immune landscape of the alveoli, are essential for immune surveillance and pulmonary surfactant homeostasis. While previous studies have reported detrimental effects of particulate matter on macrophages, little effort has been made to its impact on the key physiological functions-chemotaxis and phagocytosis-of TR-AMs, the most predominant macrophage lineage in the lung. We found that DPM exposure markedly altered gene expression profiling in murine TR-AM cell line MH-S, notably downregulating genes related to cytoskeleton actin dynamics, chemotaxis, and bacterial recognition. Both MH-S cells and primary TR-AMs displayed impaired migration and phagocytosis of Escherichia coli and Staphylococcus aureus, associated with reduced filamentous actin (F-actin) polymerization and filopodia formation. Cytochalasin D treatment further confirmed the role of actin remodeling in bacterial engulfment. In vivo, DPM exposure reduced the proportion of highly phagocytic TR-AMs, accompanied by inefficient clearance of pulmonary surfactant, leading to accumulation of Periodic acid-Schiff-positive granules, elevated surfactant protein D, and excessive lipids in both alveoli and bronchoalveolar lavage fluid (BALF). Further compositional analysis of BALF revealed excessive accumulation of phosphatidylcholine, ceramide, and cholesterol in DPM-exposed mice. In conclusion, DPM disrupts F-actin-dependent migration and phagocytosis in TR-AMs, undermining alveolar immune surveillance and surfactant homeostasis. These results highlight a key mechanism by which air pollution compromises lung defense, offering insight into particulate matter-related respiratory disease pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.